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Abstract 
The amyloid precursor protein (APP) is an integral 
membrane component of eukaryotic cells. A variety of 
research approaches have addressed the contribution of 
the (3 amyloid peptide region of the APP to neuritic 
plaque structure and formation in the Alzheimer disease 
brain as well as the relationship between (3 amyloid ac-
cumulation and the occurrence of dementia. However, 
there is limited information available concerning the 
cellular consequences of amyloid deposition. The pres-
ent studies were undertaken to investigate the relation-
ship between (3 amyloid and intercellular junctions. 
Transfected PC12 cell lines, that overexpress the (3 amy-
loid peptide, exhibit structural and functional alterations 
at the cell surface and tend to form aggregates more 
readily than normal control cells. Intermediate junctions 
were the most common intercellular interactions of both 
normal and transfected cells. However, the control and 
transfected cells differed since areas of continuous and 
extensive junctions were readily seen in transfected cells 
and infrequently seen in control cells. The data suggest 
that excess accumulation of (3 amyloid is associated with 
the junctional apparatus and may be related to increased 
intercellular adhesion. 
Key Words: Amyloid, Alzheimer, cell junctions, trans-
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Introduction 
Alzheimer's disease (AD) is the most common of 
the dementing illnesses leading to impaired intellectual, 
occupational and social performance (Katzman, 1986). 
It is the most common form of adult-onset dementia and 
is the fourth leading cause of death in the United States 
(Hay and Ernst, 1987). Among the neuropathological 
changes found in the brain, high concentrations of senile 
plaques containing (3 amyloid are observed in cerebral 
cortex, subcortical structures, and cerebellum. (3 amy-
loid is composed of fibrils of 4-8 nm diameter. The 
protein forms the cores of plaques and is found in con-
gophilic angiopathy of Alzheimer brain (G Jenner et al., 
1981; Masters et al., 1985). 
Beta amyloid is a peptide of approximately 4 kDa 
derived from a much larger glycoprotein, the amyloid 
precursor protein (APP) (Dyrks et al., 1988; Esch et 
al., 1990; Kang et al., 1987). The latter exists in multi-
ple transmembrane forms (APP695 , APP 751 , APP770) 
that result from alternative splicing of primary tran-
scripts of a single precursor gene (Kitaguchi et al., 
1988). Fragments of APP containing the (3 amyloid 
peptide have been found in normal brains (Ghiso et al., 
1992) and cerebrospinal fluid (Palmert et al., 1990), 
suggesting that (3 amyloid has a normal but unknown 
role. Determination of the function of the (3 amyloid 
peptide may help to clarify the mechanism of formation 
and the consequences of amyloid deposition that occurs 
specifically in the AD brain. 
There is evidence to suggest that APP plays a role 
in cell-cell and cell-matrix interactions (Breen et al., 
1991; Chen and Yankner 1991; de Sauvage and Octave, 
1989; Dyrks et al., 1988; Klier et al., 1990; Shivers et 
al., 1988; Ueda et al., 1989). This putative function ap-
pears to be due, at least in part, to an amino acid se-
quence located within the (3 amyloid peptide (Chen and 
Yankner, 1991; Ghiso et al., 1992). However, it is not 
known how (3 amyloid is related to the organization of 
cellular and membranous molecules that are responsible 
for maintenance of the cellular matrix and intercellular 
junctions. 
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Interactions between cells may influence their viabil-
ity and functional roles within tissues (Bissell and Bar-
cellos-Hoff, 1978; Farmer et al., 1978; Singer, 1992; 
Vasiliev, 1985). Changes in inter-neuronal associations, 
the relationships between neurons and other cell types, 
and their relationship to the microenvironment are impli-
cated in brain aging (Vemadakis, 1985). Modifications 
in membranous structures including synaptic and non-
synaptic junctions (Terry et al., 1991), which may re-
quire cell adhesion molecules, may be prerequisites for 
the acquisition of memory (Bailey and Kandel, 1993). 
The role, if any, of the transmembrane amyloid precur-
sor protein and the f3 amyloid peptide in modulating 
cellular interactions is unknown. 
To begin to explore the relationship between f3 amy-
loid and cell-cell interactions, we examined the morpho-
logical consequences of overexpressing the human 
(3 amyloid-C-terminal peptide in rat pheochromocytoma 
(PC12) cells (Maestre et al., 1992a,b, 1993; Majocha et 
al., 1993; Tate et al., 1991). PC12 cells were perma-
nently transfected with human amyloid precursor protein 
(APP) DNA that codes for 97 amino acids. These rep-
resent 40 f3 amyloid residues followed by the remainder 
of the C-terminal region of the APP (Marotta et al., 
I 989). 
In the present work, the cells were characterized by 
light (LM) and transmission electron microscopy (TEM) 
with immuno-staining. By these approaches, we deter-
mined whether or not contacts established by cells that 
overexpress f3 amyloid were uniquely different from 
those formed by control cells. 
Materials and Methods 
Preparation of transfected cells 
The initial cloning vehicle was an SV40-based vec-
tor, Pko + RI/ML, composed of PMLi, a derivative of 
PBR322 (lacking certain prokaryotic sequences poison-
ous for eukaryotic cell replication), the Lac UV5 promo-
tor of E. coli, and SV 40 sequences covering the en-
hancer, origin of replication, early promotor, t/T antigen 
splice sites and polyadenylation sites. Modification of 
the initial vector was carried out to produce three vari-
ants, Min + I, + 2 and + 3, with three different transla-
tional reading frames utilizing the ATG codon of the T/t 
antigen (Marotta et al., 1989). The starting vector or 
modified forms were used for experimentation. The 
precursor to the Min series contained a unique Pvull site 
(enhancer start) and a Barn HI site (poly A addition 
site), both of which were modified to Xbal sites by 
standard techniques. 
From an AD brain complementary DNA (cDNA) 
expression vector library prepared with bacteriophage 
lambda, we obtained an insert, referred to as amy37, 
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that included the A4 sequence and the flanking regions 
(Zain et al., 1988). The Min vector constructs were 
used for insertion of the EcoRI digested amy37 cDNA 
fragment into the three translational reading frames. 
Vectors were digested with EcoRI restnct10n 
endonuclease, to cleave at the unique EcoRI site, and 
with alkaline phosphatase. The lambda gtll-amy37 
chimera (Zain et al., 1988) was digested with EcoRI 
enzyme, and the 1.1 kb long fragment, containing the 
A4 site, was isolated. The 1.1 kb fragment was ligated 
into the Min vectors by established techniques. The 
amy37-l. l kb chimeric plasmids generated separately in 
the three reading frames were propagated; the DNA was 
isolated, purified, and used for transfection experiments 
(see below). Sequence analyses were carried out as 
described elsewhere (Zain et al., 1988). Earlier 
transfections were applied to COS-I, CV-1, HS683, SK-
N-SH and Al72 cell lines. The cells used in the present 
studies were PC12 cells, derived from rat adrenal 
pheochromocytoma obtained from Dr. ltzak Fisher 
(Medical College of Pennsylvania, Philadelphia). 
Permanent transfection experiments were conducted 
using the general procedures of van der Eb and Graham 
(1980). Integration of the 1.1 kb amyloid cDNA insert 
was carried out as described above except that the trans-
fection medium contained 10 µg of vectors with amy37-
l. l inserts. Controls consisted of vector DNA without 
an amyloid cDNA insert. Five µg PSV 2CAT DNA (the 
chloramphenicol acetyltransferase gene cloned into an 
SV 40 based plasmid), and 5 µg of Pko + Neo plasmid 
DNA (in an SV 40 based plasmid) was used. The latter 
carried the gene for Neomycin resistance that was sensi-
tive to Geneticin. CAT (chloramphenicol acetyl 
transferase) assays to assess transfection efficiency were 
carried out according to Gorman et al. (1982). The 
various transfectants were selected for survival in the 
presence of Geneticin (G418, GIBCO) at a concentration 
of 0.4 gm/I for 6 days, and then at 0.3 gm/I for 3 days; 
the cells were subsequently maintained at 0.2 gm/I. The 
cells shown in accompanying figures had undergone at 
least 20 cell divisions. Integration and expression of the 
DNA insert was confirmed by southern, northern, and 
western blot analyses in addition to immunocytochemical 
staining with anti-(3 amyloid monoclonal antibodies 
(Mabs) (Maestre et al., 1992a; Tate et al., 1992). 
Methodology for cell preparation and fixation 
Cells were grown in 35 mm plastic plates. For 
Coomassie blue staining, cells were prefixed in Hanks 
buffered saline with 5 mM EGT A/well and 200 µl 2 % 
glutaraldehyde was added to fix the cells overnight. The 
cells were subssequently rinsed with 10 % methanol 
(MeOH) for two minutes, 20 % MeOH for two minutes, 
(3 amyloid and intercellular junctions 
Figure l. Light microscopy of control and (3 amyloid positive PC12 cells stained with Coomassie brilliant blue demon-
strating the tendency to form aggregates. (A) Normal control (NN) cells. (B) Vector transfected control (V120) cells 
lacking a (3 amyloid insert. (C) (3 amyloid positive transfected AC126 cells. (D) (3 amyloid positive transfected AC127 
cells. Bar = 50 J-lm. 
and then stained with 0.1 % Coomassie blue in 20 % 
MeOH for two minutes and 1 % acetic acid for 20 min-
utes. For destaining, the cells were rinsed with 20% 
MeOH plus 1 % acetic acid for two minutes. The cells 
were finally rinsed twice in 1 % acetic acid. 
Cells were fixed with 2 % paraformaldehyde, 2.5 % 
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 
30 minutes, postfixed with OsO4 for 30 minutes, dehy-
drated through graded ethanols, and embedded in Epon 
on cover-slipped glass slides. The plates were rinsed 
briefly with Hank's salt solution and fixed with fresh 4% 
paraformaldehyde in 0.13 M NaCl, 0.02 M phosphate 
buffer, pH 7.4 (phosphate buffered saline, PBS) for 30 
minutes at room temperature. They were rinsed 3 times 
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with PBS for 10 minutes each time. Thin sections (60 
nm) were cut using an ultramicrotome and placed on 
grids which were then examined with a JEOL 1200 EX 
transmission electron microscope. 
Transmission electron microscopy immunocyto-
chemical study 
After the cells reached a confluence of approximate-
ly 75 % , the plates were rinsed with Hank's salt solution 
and fixed with 4% paraformaldehyde in 0.13 M NaCl, 
0.02 M phosphate buffer, pH 7.4 (PBS) for 30 minutes 
at room temperature. They were rinsed 3 times with 
PBS. Cells were immunostained with Mabs (IgG) pre-
pared against a synthetic polypeptide with the (3 amyloid 
sequence as reported by Masters et al. (1985). As 
G.E. Maestre et al. 
shown elsewhere (Majocha et al., 1988), the Mabs were 
highly specific for {3 amyloid. Primary antibody super-
natants were diluted 1:5 in ANP buffer (2 % bovine 
serum albumin, 0.3 M NaCl, 0.02 M phosphate, pH 
7.2) containing 0.01 % Triton X-100. Incubation was 
overnight at 4 °C. The following day, cells were washed 
3 times (for 10 minutes each) with buffer containing 0.3 
M NaCl and 20 mM Tris, followed by 2 hour incubation 
with 5 µglml of biotinylated goat anti-mouse lgG 
[Jackson lmmunoresearch in buffer (without detergent)]. 
Cells were washed as before. They were then incubated 
with strepavidin-horseradish-peroxidase conjugate 
(Sigma) at 0.25 µglml in ANP buffer (without detergent) 
for 2 hours and washed as above. The chromogen used 
was diaminobenzidine (Sigma) 0.5 mg/ml, imidazole 
(Sigma) 1 mg/ml, in 100 mM Tris, pH 7.0. Hydrogen 
peroxide was added just before use at 0.015 % (1 µl of 
30% H20 2/2 ml). The reaction was allowed to proceed 
for 2 minutes at room temperature followed by two 
rinses with distilled water. The cells were then post-
fixed in 2 % glutaraldehyde. Identification of cellular 
junctions was according to established procedures 
(Ghadially, 1988; Quinonez and Simon, 1988). 
Staining of actin 
Control and {3 amyloid-positive transfected cell lines 
were grown as above for 48 hours on glass slides coated 
with poly(L-lysine) and fixed with 4 % paraformaldehyde 
for 5 minutes. The cells were incubated at room tem-
perature for 30 minutes in Hank's solution containing 1 
µM rhodamine-phalloidin. The cells were then post-
fixed with 4 % paraformaldehyde for 10 minutes; the 
slides were rinsed and coverslipped. Photographs were 
taken using an inverted microscope (Bio Star) equipped 
with a 35 mm camera and epifluorescence optics. 
Results 
Light microscopy 
The {3 amyloid positive transfectants (AC126 and 
AC127), when compared to normal control cells (NN) 
cells that were transformed by the transfecting vector 
minus the {3 amyloid DNA (V120) plated at the same 
concentration, tended to form aggregates (Figure 1). 
The current experiment confirmed an earlier observation 
(Tate et al., 1992). The AC126 and AC127 transfect-
ants displayed a more cohesive arrangement in culture 
and the points of intercellular contact were therefore 
more extensive and numerous than in control cells 
(Figure 1). 
Transmission electron microscopy (TEM) 
TEM was performed to determine whether or not 
contacts established by cells that overexpress {3 amyloid 
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were uniquely different from those formed by control 
cells. At the ultrastructural level, the transfected AC126 
and AC127 cells demonstrated more extensive areas of 
intercellular contact than in the non-transfected control 
cells. The diverse intercellular junctions were analyzed 
and subclassified into the following categories: 
Intermediate junctions. The most commonly ob-
served junctions were of the intermediate type (Figs. 2C 
and 2D). They displayed some variability in appear-
ance: in extended areas of intercellular contact, extensive 
intermediate type junctions were observed. This type of 
junction was more commonly observed in transfected 
cells as compared to control cells. The majority were 
characterized by paired subplasmalemmal densities that 
were up to 30 nm thick. The inter-membrane thickness 
was approximately 25 nm. Occasional subplasmalernmal 
densities were associated with an increased concentration 
of adjacent cytoplasmic intermediate filaments. The fila-
ments were frequently organized in a parallel plane to 
the plasma membrane without a well developed perpen-
dicular arrangement. Shorter less extensive intermediate 
type junctions were also identified. This type of inter-
mediate junction appeared to be more readily observable 
in control cells than in transfected cells. Occasionally, 
this junctional type formed the only points of contact be-
tween control cells. Infrequent intermediate junctions 
demonstrated a better developed perpendicular arrange-
ment of intermediate filaments and, therefore, more 
closely resembled desmosomes. Well formed desmo-
somes were not identified in either control (Figs. 2A and 
2B) or transfected cells (Figs. 2C and 2D). 
Hemi-subplasmalemmaljunctions. Very occasion-
al hemi-cell junctions were observed in PC12 cells in the 
absence of cell contact (Fig. 3A). These were charac-
terized by areas of increased subplasmalemmal density 
without an associated perpendicular arrangement of in-
termediate filaments to the cell membranes. In some in-
stances, an intercellular space between cells displaying 
these junctions contained a fine granular material of un-
known nature. The intercellular distances at junctions 
were wide and measured approximately 100 nm. At 
these points, subplasmalemmal densities were observed. 
In the present study, the hemi-subplasmalemma junctions 
were not observed in amyloid-positive transfectants, 
however, they may be present to a minor extent relative 
to control levels. 
Tight junctions. Both transfected and non-trans-
fected control cells showed occasional points of very 
close intercellular approximation of cell membranes. 
They appeared as a series of focal connections between 
membranes of adjacent cells. These structures were in-
terpreted as resembling tight junctions (Fig. 3B). On the 






(A) Normal control 
(NN) cells. 
(B) Vector trans-
fected control (V120) 
cells lacking a 
(3 amyloid insert. 
(C) (3 amyloid posi-
tive transfected 
AC127 cells. 
(D) (3 amyloid posi-
tive transfected 
AC127 cells. 
In areas of extended 
intercellular contact, 
intermediate type 
junctions were well 
formed. There is a 
corresponding organ-
ized arrangement of 
microfilaments, inter-
mediate filaments, 
and microtubules in 
the underlying cellu-
lar cytoplasm. The 
intermediate filaments 
and microtubules are 
oriented parallel to 
the cellular mem-
brane. 
Bars = 200 nm. 
(3 amyloid and intercellular junctions 
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Figure 3. Transmission electron micrographs demonstrating a tight junction and hemi-subplasmalemmal junction. (A) 
(3 amyloid positive transfected AC127 cells showing a tight junction. (B) NN normal control PC12 cells showing hemi-
subplasmalemmal densities. Bars = 100 nm. 
fJ amyloid epitope at contact sites 
The possible relationship between the accumulation 
of the (3 amyloid peptide and intercellular contact sites 
was assessed by imrnunocytochemistry and studied with 
TEM in both (3 amyloid-positive transfectants (Figs. 4B 
and 4C) and in control cells (Fig. 4A). The areas of 
imrnunostaining for the (3 amyloid epitope corresponded 
to the areas of extended intercellular contact (Figs. 4B 
and 4C). This pattern of imrnunostaining was not ob-
served in control cells (Fig. 4A). A corresponding par-
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allel arrangement of intermediate filaments in the sub-
plasmalemrnal region was occasionally associated with 
membranous imrnunostaining for (3 amyloid. 
To demonstrate that the immunostain label was the 
result of specific (3 amyloid accumulation, an unrelated 
control MAB, anti-ribonuclease inhibitor protein (RIP) 
(Majocha et al., 1987), was used for comparative analy-
sis. Even though identical procedures were employed, 
the anti-RIP MAB did not deposit on membranes or 
intercellular spaces (Maestre et al., 1992a). 
f3 amyloid and intercellular junctions 
Figure 4. Transmission electron m.icrographs of immuno-stained control and f3 amyloid positive transfected PC12 cells 
using monoclonal antibodies to the /3 peptide region of the APP. (A) Normal control (NN) cells. (B) f3 amyloid 
positive transfected AC126 cells. (C) f3 amyloid positive transfected AC127 cells. In B and C, immuno-positive 
material is present in appreciable quantities at the intercellular junctions. Bar = 640 nm. 
Distribution of actin. Cells were stained with phal-
loidin-rhodamine and studied at the LM level. As sug-
gested by the TEM observations, actin accumulated sub-
apically in linear bundles that coursed parallel to the 
edge of the /3 amyloid-positive cell types (Figs. SC and 
SD). By contrast, in control cells actin was more con-
centrated at the tip of neurites (Figs. SA and SB). When 
two adjacent control cells were observed, little or no 
accumulation of actin was observable (Figs. SA and SB). 
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Discussion 
Transfected PC12 cell lines that overexpress the 
f3 amyloid peptide exhibit structural and functional 
alterations at the cellular surface. We previously 
reported that these cells display increased numbers of the 
membrane elaborations, including m.icrovilli and blebs 
(Maestre et al., 1992a), enhanced ruffling activity 
(Maestre et al., 1993), and modified cell-substrate adhe-
sion properties (Maestre et al., 1992b). Here, we report 
G.E. Maestre et al. 
Figure 5. Fluorescence microscopy of control and /3 amyloid positive PC12 cells stained with phalloidin-rhodamine 
to demonstrate the redistribution of immunofluorescent actin fibers after transfection with /3 amyloid DNA. (A) No.rmal 
control (NN) cells. (B) Vector transfected control (V120) cells lacking a /3 amyloid insert. (C) /3 amyloid positive 
transfected AC127 cells photographed to emphasize the intercellular junctions. (D) /3 amyloid positive transfected 
AC127 cells photographed to emphasize the intracellular distribution of actin fibers. Bar = 70 µm. 
----------------------------------------------------------------------------------------------
that intercellular contact is also affected in /3 amyloid 
positive cells. The cells have a greater tendency to form 
aggregates than do normal control. PC12 cells or PC12 
cells transfected with a vector lacking the /3 amyloid-C-
terminal insert. Increased electron density was found at 
the junctional membrane sites of transfected cells over-
expressing /3 amyloid. 
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The more commonly observed type of junction that 
mediates clustering in the /3 amyloid positive aggregates 
is the intermediate junction. Although intermediate type 
junctions were also seen in control cells, the occurrence 
of continuous and extensive intermediate type junctions 
was common in transfected cells that overexpressed 
amyloid. However, tight junctions and hemi-subplasma-
{3 amyloid and intercellular junctions 
lemma! densities were also noted. Intercellular struc-
tures resembling tight junctions, but not gap junctions, 
were found in control and {3 amyloid-positive transfected 
cells. Freeze etching techniques could be employed to 
make a more definitive identification of the tight junc-
tions and to conclusively exclude the occurrence of gap 
junctions. 
There are multiple determinants that influence the 
type of junction that can form. These include environ-
mental cues and tissue distribution (Chiu et al., 1992); 
regeneration (Gluck et al., 1992); and the stage of de-
velopment (Duband and Thiery, 1990). Junctions are 
also influenced by rearrangements of cytoskeletal com-
ponents such as the accumulation of actin bundles at the 
cytoplasmic surface of the plasma membrane (Volberg 
et al., 1986). Current investigations are aimed at 
identifying neuronal markers, including cytoskeletal 
constituents, that may be perturbed by overaccumulation 
of the {3 amyloid peptide. In a concurrent study, we 
observed that {3 amyloid-positive transfectants exhibited 
reduced levels of neurofilaments and synaptophysin 
(Majocha et al., 1992). 
Neither the role of the {3 amyloid peptide in the 
formation of specific junctional types, nor the conse-
quences of this process for intercellular communication, 
if any, are currently understood. However, certain rele-
vant observations can be cited. In the transfected PC12 
cells, the {3 amyloid-C terminal region of the APP that 
is overexpressed includes the transmembrane domain 
(Marotta et al., 1989). The {3 amyloid antigen colocal-
izes with the membrane (Maestre et al., 1993); and from 
in vitro studies, it is known that the {3 peptide has a 
strong tendency to self-aggregate (Gorevic et al., 1987; 
Halverson et al., 1990; Honda and Marotta, 1992; 
Kirschner et al., 1987). Based on these observations, 
we can hypothesize that overexpression of the {3 amyloid 
peptide enhances the ability of the cell to form symmet-
rical junctions directly or indirectly. A direct role may 
include homotypic binding among {3 amyloid peptides at 
the surface of two cells; or, heterotypic binding may oc-
cur which would include the interaction between {3 ?my-
loid amino acids and a receptor or ligand on another 
cell. It is possible that the observed effects are due to 
a non-{3-amyloid region of the overexpressed protein. 
Indeed, although {3 amyloid peptide has been shown to 
be toxic in some circumstances, it has also been reported 
that other regions of the c-terminal fragment not involv-
ing the amyloid region can also be toxic to PC12 cells 
(Kozlowski et al., 1992). Therefore, additional studies 
are necessary to confirm that the observations reported 
here are due to {3 amyloid peptide alone. 
Structural changes that underlie the acquisition of 
memory support the notion that synaptic growth occurs 
at the expense of non-synaptic junctions (for review, see 
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Bailey and Kandel, 1993). Deficits in memory are a 
clinical hallmark of AD, and this impairment may be di-
rectly related to the compromised integrity of intemeu-
ronal interactions. We provided evidence that excess ac-
cumulation of {3 amyloid C-terminal peptide is related to 
increased intercellular adhesion and that the peptide is 
associated with the intercellular junctional apparatus. 
The {3 amyloid peptide may compromise membrane in-
tegrity (Arispe et al., 1993; Nitch et al., 1992) and me-
diate membrane turnover at these sites. This suggested 
process would interfere with dynamic neuronal connec-
tivity and synaptic growth. To some extent this pro-
posed mechanism may be reflected by the differences in 
actin distribution we observed in {3 amyloid positive cells 
compared with controls. 
Thus, among the consequences of the suggested 
processes may be memory impairment. Alterations in 
intercellular interactions in the AD brain have not been 
directly explored to a notable extent. Genetically engi-
neered PC12 cells transfected with the C-terminal region 
of APP DNA provide important opportunities to analyze 
intercellular alterations that are directly associated with 
the accumulation of the {3 amyloid peptide. These stud-
ies will extend our understanding of cellular mechanisms 
associated with {3 amyloid that contribute to the dementia 
of AD. 
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Discussion with Reviewers 
F.N. Low: The author's interpretations of cell junc-
tions, particularly in the transmission electron micro-
graphs, would not be approved by critical cell biologists 
(although not necessarily wrong). For example, in Fig-
ure 3A, the tight junction does not show pentalaminar 
organization. This may be because it is cut diagonally 
in a section too thick for satisfactory identification. . 
Authors: Prof. Low justifiably addresses the difficulties 
in confirming tight junctions in this material. For the 
purpose of clarification, a tight junction was defined as 
follows: "A tight junction consists of a series of punctu-
ate contacts in which the dense outer leaflets of adjoin-
ing membranes converge and fuse to form a single line. 
Often, the outer dense line of the outer membrane is in-
terrupted at the sites of membrane fusion. The width of 
diffused membranes is slightly less than the combined 
width of the two unit membranes" (Quinonez and 
Simon, 1988). Prof. Low's comments concerning the 
thickness of the section are appreciated. In fact, as 
mentioned in text, freeze-fracturing techniques could be 
employed to better study gap junctions and tight junc-
tions; these techniques were not utilized in this study. 
Based upon the limitations of the techniques that we 
used in our study, the example of tight junction present-
ed in this paper should still be acceptable considering the 
above cited definition for this type of junction. 
G.E. Maestre et al. 
G.D. Miner: What is the relative importance of {3 amy-
loid to the basic causes of Alzheimer's Disease consider-
ing the chromosome 14AD gene, the chromosome 19 
(APO-E4) gene, the chromosome 21 ("FAD") gene, and 
the yet to be discovered chromosome location of the 
Volga-German early onset FAD? 
Authors: The relative importance of 13 amyloid in the 
pathogenesis of AD is unknown. The current view is 
that AD is a heterogeneous syndrome, from both a clini-
cal and a genetic point of view. The fact that mutations 
in the APP gene (chromosome 21) are sufficient to cause 
AD has been the major argument in favor of amyloid as 
an active participant in the events that lead to degenera-
tion in the brains of AD victims. In addition, even 
though linkage of AD and chromosome 14 and 19 have 
been reported, the mechanisms for which these loci 
could be pathogenic are uncertain. In the case of the 
Apoliproprotein E gene (ApoE) on chromosome 19, pre-
cise definition as an AD susceptibility gene or as a gene 
in linkage disequilibrium with the "true AD gene" is 
necessary. However, in families with APP mutations, 
the e-4 genotypes predispose to earlier onset, which 
suggest that ApoE could be a "modifier" instead of a 
determinant factor in the pathogenic pathway leading to 
AD [Alzheimer's Disease Collaborative Group (1993). 
Apolipoprotein E genotype and Alzheimer's disease. 
Lancet 342: 737-738; and St. George-Hyslop P, Crapper 
McLachlan D, Tuda T, Rogaev E, Karlinsky H, Lippa 
CF, Pollen D ( 1994). Alzheimer's disease and possible 
gene interaction. Science 263: 537). 
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G.D. Miner: Are there any specific and differing (i.e., 
variant) functions or purposes of the three transmem-
brane forms of APP (e.g., APP695 , APP 751 and APP770) 
known? Are there any important reasons for these mul-
tiple forms, or is it a redundancy built into the bio-
chemical genetic system? 
Authors: The expression of the amyloid precursor pro-
tein (APP) gene is highest (all forms) during neurologi-
cal development. The dominant form in the brain is the 
695 isoform, whose expression has previously been 
found to be largely restricted to the central nervous 
system. During neonatal development in the rat basal 
forebrain, the ratio between isoform 695 and other 
Kunitz containing APP's is the highest. The precise 
function of APP during development, or at any other 
time for that matter, is not known [Sherman CA, 
Higgins GA (1992). Regulated splicing of the amyloid 
precursor protein gene during postnatal development of 
the rat basal forebrain. Brain Res Dev Brain Res 6: 63-
69). 
